Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong
· Delayed Price · Currency is HKD 1.860
+0.010 (0.54%)
Apr 29, 2026, 4:08 PM HKT
Venus Medtech (Hangzhou) Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | - | -714.31 | -703.75 | -1,058 | -373.64 | Upgrade
|
| Depreciation & Amortization | - | 66.47 | 76.67 | 108.36 | 48.76 | Upgrade
|
| Other Amortization | - | 44.64 | 48.11 | 3.99 | 2.87 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -3.53 | 1.27 | 0.13 | 0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 187.99 | 248.78 | 420.23 | 236.15 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 81.01 | -21.29 | 0.19 | 0.66 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 4.15 | 12.38 | 13.94 | 11.71 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 21.44 | -2.21 | 21.97 | 3.05 | Upgrade
|
| Other Operating Activities | - | 26.29 | -152.55 | -98.26 | -239.77 | Upgrade
|
| Change in Accounts Receivable | - | 90.95 | 14.21 | -7.85 | -74.13 | Upgrade
|
| Change in Inventory | - | -0.59 | -26.18 | -13.68 | -29.18 | Upgrade
|
| Change in Accounts Payable | - | 4.85 | 24.73 | 0.38 | 3.46 | Upgrade
|
| Change in Unearned Revenue | - | -27.96 | 26.25 | -12.92 | 0.29 | Upgrade
|
| Change in Other Net Operating Assets | - | 242.35 | -156.44 | -108.26 | -47.28 | Upgrade
|
| Operating Cash Flow | - | 23.74 | -610.02 | -729.46 | -456.92 | Upgrade
|
| Capital Expenditures | - | -33.92 | -260.64 | -169.98 | -82.07 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 14.62 | 2.91 | 9.41 | - | Upgrade
|
| Cash Acquisitions | - | - | - | -813.49 | -124.59 | Upgrade
|
| Divestitures | - | -0.48 | - | - | 22.5 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -7.64 | -2.27 | -8.79 | -19.71 | Upgrade
|
| Sale (Purchase) of Real Estate | - | - | - | - | -43.39 | Upgrade
|
| Investment in Securities | - | - | -18.77 | -98.17 | -416.78 | Upgrade
|
| Other Investing Activities | - | 7.52 | -68.09 | 4.76 | 15 | Upgrade
|
| Investing Cash Flow | - | -19.9 | -346.86 | -1,072 | -653.04 | Upgrade
|
| Long-Term Debt Issued | - | 104.03 | 413.48 | 939.14 | - | Upgrade
|
| Total Debt Issued | - | 104.03 | 413.48 | 939.14 | - | Upgrade
|
| Long-Term Debt Repaid | - | -563.26 | -543.81 | -237.46 | -20.25 | Upgrade
|
| Total Debt Repaid | - | -563.26 | -543.81 | -237.46 | -20.25 | Upgrade
|
| Net Debt Issued (Repaid) | - | -459.23 | -130.34 | 701.68 | -20.25 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,206 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -72.55 | Upgrade
|
| Other Financing Activities | - | -28.11 | -43.65 | -66.55 | 278.31 | Upgrade
|
| Financing Cash Flow | - | -487.34 | -173.99 | 635.14 | 1,391 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 7.14 | 25.83 | 90.81 | -34.4 | Upgrade
|
| Net Cash Flow | - | -476.36 | -1,105 | -1,076 | 247.04 | Upgrade
|
| Free Cash Flow | - | -10.18 | -870.66 | -899.44 | -538.99 | Upgrade
|
| Free Cash Flow Margin | - | -2.16% | -177.19% | -221.28% | -129.61% | Upgrade
|
| Free Cash Flow Per Share | - | -0.02 | -1.99 | -2.05 | -1.23 | Upgrade
|
| Cash Interest Paid | - | 28.61 | 61.69 | 43.81 | 1.96 | Upgrade
|
| Cash Income Tax Paid | - | 0.95 | 3.44 | 3.07 | 8.65 | Upgrade
|
| Levered Free Cash Flow | - | 155.46 | -717.63 | -559.42 | -268.15 | Upgrade
|
| Unlevered Free Cash Flow | - | 165.86 | -678.43 | -531.53 | -266.96 | Upgrade
|
| Change in Working Capital | - | 309.59 | -117.43 | -142.32 | -146.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.